Critical reviews in oncology/hematology
-
Crit. Rev. Oncol. Hematol. · Jan 2020
ReviewPrevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by many of the most commonly used chemotherapeutic agents, including taxanes, vinca alkaloids, and bortezomib. ⋯ This review focuses on the etiology of CIPN and will highlight the various approaches developed for prevention and treatment. The goal is to guide studies to identify, test, and standardize approaches for managing CIPN.